Obesity is associated with secondary hyperparathyroidism in men with moderate and severe chronic kidney disease

Csaba Kovesdy, Shahram Ahmadzadeh, John E. Anderson, Kamyar Kalantar-Zadeh

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background and Objectives: Obesity is associated with secondary hyperparathyroidism in the general population. The objective of this study is to explore whether the same association is present in patients with chronic kidney disease. Design, Setting, Participants & Measurements: Linear regression models were used to examine the association between intact parathyroid hormone level and body mass index in 496 male US veterans (age 69.4 ± 10.2 yr, 22.8% black) who had chronic kidney disease stages 2 to 5 and were not yet on dialysis (estimated GFR 31.8 ± 11.2 ml/min per 1.73 m2). Results: Higher intact parathyroid hormone was associated with higher body mass index after adjustment for age, race, diabetes, and serum calcium and phosphorus levels. This association was independent of age, race, diabetes status, and serum calcium and phosphorus but was limited to patient groups with lower albumin (P = 0.005 for the interaction term) or higher white blood cell count (P = 0.026 for the interaction term). Conclusions: Higher body mass index is associated with secondary hyperparathyroidism in patients who have chronic kidney disease and are not yet on dialysis, especially in patients with evidence of malnutrition and inflammation. Confirmation of these findings in other patient groups with chronic kidney disease and better characterization of the underlying mechanisms of action will be necessary before advocating weight loss as a means to treat secondary hyperparathyroidism in chronic kidney disease.

Original languageEnglish (US)
Pages (from-to)1024-1029
Number of pages6
JournalClinical Journal of the American Society of Nephrology
Volume2
Issue number5
DOIs
StatePublished - Sep 1 2007

Fingerprint

Secondary Hyperparathyroidism
Chronic Renal Insufficiency
Obesity
Body Mass Index
Parathyroid Hormone
Phosphorus
Dialysis
Linear Models
Calcium
Veterans
Serum
Leukocyte Count
Malnutrition
Weight Loss
Albumins
Inflammation
Population

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Critical Care and Intensive Care Medicine
  • Nephrology
  • Transplantation

Cite this

Obesity is associated with secondary hyperparathyroidism in men with moderate and severe chronic kidney disease. / Kovesdy, Csaba; Ahmadzadeh, Shahram; Anderson, John E.; Kalantar-Zadeh, Kamyar.

In: Clinical Journal of the American Society of Nephrology, Vol. 2, No. 5, 01.09.2007, p. 1024-1029.

Research output: Contribution to journalArticle

@article{c186c9d78a444101832ab7f786624464,
title = "Obesity is associated with secondary hyperparathyroidism in men with moderate and severe chronic kidney disease",
abstract = "Background and Objectives: Obesity is associated with secondary hyperparathyroidism in the general population. The objective of this study is to explore whether the same association is present in patients with chronic kidney disease. Design, Setting, Participants & Measurements: Linear regression models were used to examine the association between intact parathyroid hormone level and body mass index in 496 male US veterans (age 69.4 ± 10.2 yr, 22.8{\%} black) who had chronic kidney disease stages 2 to 5 and were not yet on dialysis (estimated GFR 31.8 ± 11.2 ml/min per 1.73 m2). Results: Higher intact parathyroid hormone was associated with higher body mass index after adjustment for age, race, diabetes, and serum calcium and phosphorus levels. This association was independent of age, race, diabetes status, and serum calcium and phosphorus but was limited to patient groups with lower albumin (P = 0.005 for the interaction term) or higher white blood cell count (P = 0.026 for the interaction term). Conclusions: Higher body mass index is associated with secondary hyperparathyroidism in patients who have chronic kidney disease and are not yet on dialysis, especially in patients with evidence of malnutrition and inflammation. Confirmation of these findings in other patient groups with chronic kidney disease and better characterization of the underlying mechanisms of action will be necessary before advocating weight loss as a means to treat secondary hyperparathyroidism in chronic kidney disease.",
author = "Csaba Kovesdy and Shahram Ahmadzadeh and Anderson, {John E.} and Kamyar Kalantar-Zadeh",
year = "2007",
month = "9",
day = "1",
doi = "10.2215/CJN.01970507",
language = "English (US)",
volume = "2",
pages = "1024--1029",
journal = "Clinical journal of the American Society of Nephrology : CJASN",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "5",

}

TY - JOUR

T1 - Obesity is associated with secondary hyperparathyroidism in men with moderate and severe chronic kidney disease

AU - Kovesdy, Csaba

AU - Ahmadzadeh, Shahram

AU - Anderson, John E.

AU - Kalantar-Zadeh, Kamyar

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Background and Objectives: Obesity is associated with secondary hyperparathyroidism in the general population. The objective of this study is to explore whether the same association is present in patients with chronic kidney disease. Design, Setting, Participants & Measurements: Linear regression models were used to examine the association between intact parathyroid hormone level and body mass index in 496 male US veterans (age 69.4 ± 10.2 yr, 22.8% black) who had chronic kidney disease stages 2 to 5 and were not yet on dialysis (estimated GFR 31.8 ± 11.2 ml/min per 1.73 m2). Results: Higher intact parathyroid hormone was associated with higher body mass index after adjustment for age, race, diabetes, and serum calcium and phosphorus levels. This association was independent of age, race, diabetes status, and serum calcium and phosphorus but was limited to patient groups with lower albumin (P = 0.005 for the interaction term) or higher white blood cell count (P = 0.026 for the interaction term). Conclusions: Higher body mass index is associated with secondary hyperparathyroidism in patients who have chronic kidney disease and are not yet on dialysis, especially in patients with evidence of malnutrition and inflammation. Confirmation of these findings in other patient groups with chronic kidney disease and better characterization of the underlying mechanisms of action will be necessary before advocating weight loss as a means to treat secondary hyperparathyroidism in chronic kidney disease.

AB - Background and Objectives: Obesity is associated with secondary hyperparathyroidism in the general population. The objective of this study is to explore whether the same association is present in patients with chronic kidney disease. Design, Setting, Participants & Measurements: Linear regression models were used to examine the association between intact parathyroid hormone level and body mass index in 496 male US veterans (age 69.4 ± 10.2 yr, 22.8% black) who had chronic kidney disease stages 2 to 5 and were not yet on dialysis (estimated GFR 31.8 ± 11.2 ml/min per 1.73 m2). Results: Higher intact parathyroid hormone was associated with higher body mass index after adjustment for age, race, diabetes, and serum calcium and phosphorus levels. This association was independent of age, race, diabetes status, and serum calcium and phosphorus but was limited to patient groups with lower albumin (P = 0.005 for the interaction term) or higher white blood cell count (P = 0.026 for the interaction term). Conclusions: Higher body mass index is associated with secondary hyperparathyroidism in patients who have chronic kidney disease and are not yet on dialysis, especially in patients with evidence of malnutrition and inflammation. Confirmation of these findings in other patient groups with chronic kidney disease and better characterization of the underlying mechanisms of action will be necessary before advocating weight loss as a means to treat secondary hyperparathyroidism in chronic kidney disease.

UR - http://www.scopus.com/inward/record.url?scp=34548826259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548826259&partnerID=8YFLogxK

U2 - 10.2215/CJN.01970507

DO - 10.2215/CJN.01970507

M3 - Article

VL - 2

SP - 1024

EP - 1029

JO - Clinical journal of the American Society of Nephrology : CJASN

JF - Clinical journal of the American Society of Nephrology : CJASN

SN - 1555-9041

IS - 5

ER -